TNF RECEPTOR-ASSOCIATED FACTOR-3 SIGNALING MEDIATES ACTIVATION OF P38AND JUN N-TERMINAL KINASE, CYTOKINE SECRETION, AND IG PRODUCTION FOLLOWING LIGATION OF CD40 ON HUMAN B-CELLS
Ac. Grammer et al., TNF RECEPTOR-ASSOCIATED FACTOR-3 SIGNALING MEDIATES ACTIVATION OF P38AND JUN N-TERMINAL KINASE, CYTOKINE SECRETION, AND IG PRODUCTION FOLLOWING LIGATION OF CD40 ON HUMAN B-CELLS, The Journal of immunology (1950), 161(3), 1998, pp. 1183-1193
CD40 engagement induces a variety of functional outcomes following ass
ociation with adaptor molecules of the TNF receptor-associated factor
(TRAF) family. Whereas TRAF2, -5, and -6 initiate NF-kappa B activatio
n, the outcomes of TRAF3-initiated signaling are less characterized. T
o delineate CD40-induced TRAF3-dependent events, Ramos B cells stably
transfected with a dominant negative TRAF3 were stimulated with membra
nes expressing recombinant CD154/CD40 ligand, In the absence of TRAM s
ignaling, activation of p38 and control of Ig production were abrogate
d, whereas Jun N-terminal kinase activation and secretion of IL-10, ly
mphotoxin-alpha, and TNF-alpha were partially blocked. By contrast, in
duction of apoptosis, activation of NF-kappa B, generation of granuloc
yte-macrophage CSF, and up-regulation of CD54, MHC class II, and CD95
were unaffected by the TRAF3 dominant negative. Together, these result
s indicate that TRAF3 initiates independent signaling pathways via p38
and JNK that are associated with specific functional outcomes.